Scorpion Therapeutics

🗓 Founded 2020👥 111 employees💰 Last funded Apr 2020
Biotechnology🌐 scorpiontx.com
Website LinkedIn
Scorpion Therapeutics was founded to expand the reach of precision medicine to more people with cancer. The company is integrating cutting-edge technologies across target discovery, medicinal chemistry, and translational medicine to deliver Precision Oncology 2.0, a pipeline of targeted small-molecule drugs that overcome the limitations of existing treatments. Scorpion’s experienced leadership team is executing a fit-to-purpose model to efficiently unlock the next generation of precision oncology. For more information, visit scorpiontx.com.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2020
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Scorpion Therapeutics?
Scorpion Therapeutics has 1 investors on record on gritt.io, including 1 early-stage backers.
When did Scorpion Therapeutics last raise funding?
The most recent investment in Scorpion Therapeutics recorded on gritt.io was in April 2020.
When was Scorpion Therapeutics founded?
Scorpion Therapeutics was founded in 2020.
What industry is Scorpion Therapeutics in?
Scorpion Therapeutics operates in Biotechnology. Find similar Biotechnology investors on gritt.io.